PGAs

Question 1

LUMIGAN
Indication
contraindication
administration
AE
DDI
max IOP reduction

Answer 1

-Reduction of elevated IOP in OAG or OHT
-hypersensitivity to bimatoprost
-QD in evening
-conjunctival hypermedia
-none
7.5 mm Hg

Question 2

LUMIGAN
Indication
contraindication
administration
AE
DDI
max IOP reduction

Answer 2

-Reduction of elevated IOP in OAG or OHT
-hypersensitivity to bimatoprost
-QD in evening
-conjunctival hypermedia
-none
7.5 mm Hg

Question 3

TRAVATAN Z
indication
Contraindications
Administration
AE
DDI
Max IOP reduction

Answer 3

-reduction of elevated IOP in OAG or OHT
-none
-QD in evening
-ocular hyperemia
-none
-7-8 mm Hg

Question 4

LATANOPROST (generic)
indication
Contraindications
Administration
AE
DDI
Max IOP reduction

Answer 4

-reduction of IOP in OAG or OHT
-hypersensitivity to latanaprost, benzalkonium chloride, or any other ingredients
-QD in evening
-foreign body sensation
-none
-6-8 mm Hg

Question 5

VYZULTA
indication
Contraindications
Administration
AE
DDI
Max IOP reduction

Answer 5

-reduction of IOP in OAG or OHT
-none
-QD in evening
-conjunctival hyperemia
-none
-7-9 mm Hg

Question 6

ZIOPTAN
indication
Contraindications
Administration
AE
DDI
Max IOP reduction

Answer 6

-reduction of elevated IOP in OAG or OHT
-none
-QD in evening
-conjunctival hyperemia
-none
-5-8 mm Hg

Question 7

XELPROS
indication
Contraindications
Administration
AE
DDI
Max IOP reduction

Answer 7

-reduction of IOP in OAG or OHT
-hypersensitivity to latanaprost or any other ingredients
-QD in evening
-eye pain/stinging
-concurrent use of eye drops containing thimerosal or other prostaglandins
-6-8 mm Hg

Question 8

LUMIGAN
active ingredient

Answer 8

Bimatoprost 0.01%

Question 9

LUMIGAN
proposed MOA

Answer 9

Increased trabecular meshwork and uveoscleral outflow

Question 10

LUMIGAN
bottle size availability

Answer 10

2.5 mL fills in a 5 mL bottle

5 mL fills in a 10 mL bottle

7.5 mL fills in a 10 mL bottle

Question 11

TRAVATAN Z
active ingredient

Answer 11

Travoprost .004%

Question 12

TRAVATAN Z
proposed MOA

Answer 12

Increase uveoscleral outflow

Question 13

TRAVATAN Z
Bottle size availability

Answer 13

2.5 mL in a 4 mL bottle

5 mL in a 7.5 mL bottle

Question 14

LATANOPROST (generic)
Active ingredient

Answer 14

Latanaprost .005%

Question 15

LATANAPROST (generic)
Proposed MOA

Answer 15

Increased uveoscleral outflow

Question 16

LATANOPROST (generic)
Bottle size availability

Answer 16

2.5 mL solution in a 5 mL bottle

Question 17

VYZULTA
Active ingredient

Answer 17

Latanaprost .024%

Question 18

VYZULTA
proposed MOA

Answer 18

Increased trabecular meshwork and uveoscleral outflow

Question 19

VYZULTA
bottle size

Answer 19

2.5 mL in a 4 mL bottle
5 mL in and 7.5 mL bottle

Question 20

ZIOPTAN
active ingredient

Answer 20

Tafluprost .0015%

Question 21

ZIOPTAN
MOA

Answer 21

Uveoscleral outflow

Question 22

ZIOPTAN
bottle availability

Answer 22

Cartons in 30 and 90 single use containers
Each have .3 mL solution corresponding to .0045 mg tafluprost

Question 23

XELPROS
active ingredient

Answer 23

Latanaprost .005%

Question 24

XELPROS
MOA

Answer 24

Uveoscleral outflow

Question 25

XELPROS
Bottle size

Answer 25

2.5 mL in a 5 mL bottle